Research Article
BibTex RIS Cite

REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ

Year 2020, , 276 - 280, 01.07.2020
https://doi.org/10.18229/kocatepetip.735941

Abstract

AMAÇ: Bu çalışmada; reflü sebebiyle opere edilen hastaların ameliyat öncesi ve ameliyat sonrası 3. ay ses handikap indekslerin (SHI) karşılaştırılması amaçlanmıştır.
GEREÇ VE YÖNTEM: Reflü sebebiyle Afyonkarahisar Sağlık Bilimleri Üniversitesi Genel Cerrahi Kliniği tarafından 2014-2017 yılları arasında opere edilen 30 hastanın Afyonkarahisar Sağlık Bilimleri Üniversitesi Kulak Burun Boğaz Kliniği tarafından ameliyat öncesi ve ameliyat sonrası 3. ay ses handikap indekslerin (SHI) karşılaştırılmıştır.
BULGULAR: Çalışmaya alınan hastaların 16’sı (%53) erkek, 14’ü (%47) kadındır. Yaş ortalaması 32.45±10.16’dır Operasyon öncesi ile karşılaştırıldığında operasyon sonrasında SHI toplam skoru ile fonksiyonel, fiziksel ve emosyonel alt grup skorlarının tümünde istatistiksel olarak anlamlı iyileşme saptanmıştır.
SONUÇ: Bu çalışmada reflü cerrahisi ve ses handikap indeks skorları arasında anlamlı bir ilişki bulundu.

References

  • 1. Chen CL, Robert JJ, Orr WC. Sleep symptoms and gastroesophageal reflux. J Clin Gastroenterol 2008;42:13-7.
  • 2. Sveen S. Symptom check: is it GERD? J Contin Educ Nurs 2009;40:103-4.
  • 3. Levine JS. Management of Barret Esophagus. Primary Care Case Reviews 2002;5:68-76.
  • 4. Hogan WJ, Shaker R. Medical treatment of supraesophageal complications of gastroesophageal reflux disease. Am J Med 2001;111:197-201.
  • 5. Castell DO, Mainie I, Tutuian R. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc 2005;116:321-3.
  • 6. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;9:15-25.
  • 7. Yorulmaz İ. Larengofarengeal reflü, derleme. KBB-Forum 2002; 1(1):22-34.
  • 8. Field SK, Unxderwood M, Brant R, Cowie RL. Prevelance of gastroesophageal reflux symptoms in asthma. Chest 1996; 109: 316-22. 64
  • 9. Harding SM, Guzzo MR, Richter JE. 24-h eshophageal pH testing in asthmatics: Respiratory symptom correlation with esophageal acid events. Chest 1999; 115: 654-9.
  • 10. Irwin RS, Curley FJ, French CL. Difficult to control asthma contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-9.
  • 11. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24- hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(Suppl 53):1-78.
  • 12.Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000; 123:385-8.
  • 13.Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001; 111:1735-41.
  • 14.Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageallaryngeal reflux. J Gastrointest Surg 2002; 6: 189-94.
  • 15.Rouev P, Chakarski I, Doskov D, et al. Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 2005; 19: 476-80.
  • 16.Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985:94:516-9.
  • 17.Book DT, Rhee JS, Toohill RJ, Smith TL. Perspectives in laryngopharyngeal reflux: An international survey. Laryngoscope 2002; 112:1399-406.
  • 18.Goldberg M, Noyek AM, Pritzker KPH. Laryngeal granuloma secondary to gastroesophageal reflux. J Otolaryngol 1978; 7: 196-202. (PMID: 691085).
  • 19.Miko TL: Peptic (contact ulcer) granuloma of the larynx. J Clin Pathol 1989; 42: 800-4. (PMID: 2768520)
  • 20.Olson NR: Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991; 24:1201-1213. (PMID: 1754220).
  • 21. Kuhn I, Toohill RJ, Ulualp SO, Kulpa J, Hofmann C, Arndorfer R, Shaker R: Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 1998; 108:1146-1149. (PMID: 9707233).
  • 22. Jindal JR, Milbrath MM, Shaker R, Hogan WJ, Toohill RJ: Gastroesophageal reflux disease as a likely cause of idiopathic subglottic stenosis. Ann Otol Rhinol Laryngol 1994; 103:186-191. (PMID: 8122834). 70
  • 23. Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ: Carcinoma of the larynx in patients with gastroesophageal reflux, Am J Otolaryngol 1996; 17:386-90. (PMID: 8944297).
  • 24. Morrison MD: Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988; 99: 370-3. (PMID: 3148885).
  • 25. Ward PH, Hanson DG: Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988; 98: 1195-9. (PMID: 3185074).
  • 26. Öktem F, Toprak M, Ada M, Öztürk Ö: Larenks kanseri etyolojisinde laringofaringeal reflünün yeri. Türk ORL Arşivi 2000; 38: 28-32.
  • 27. Sataloff RT, Abaza MM. İmpairment, disability and other medical-legal aspects of dysphonia. Otolaryngol Clin North Am. 2000; 33 (5): 1143-1152.
  • 28. Speyer R, Bogaarrdt HCA, Passos VL, Roodenburg NP, Zumach A, Heinen MA et al.
  • 29. Gelfer MP, Pazera JF. Maximum duration of sustained /s/ and /z/ and s/z ratio with controlled intensity. J Voice. 2006; 20: 369-79.
  • 30. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. Voice. 1998; 12 (4): 540- 550.
  • 31. Jacobson BH, Johnson A, Grywasky C. The Voice Handikap Index (VHI): development and validation. J Voice. 1998; 12: 540-550.
  • 32. Mc Croy E. Voice therapy outcomes in vocal fold nodules: a retrospective audit. Int J Lang Commun Disord. 2001; 36: 19-24.
  • 33. Amir O, Tavor Y, Leibovitzh T, Ashkenazi O, Michael O, Primov-Fever A, et al. Evaluating the validity of the Voice Handicap Index-10 (VHI-10) among Hebrew speakers. Otolaryngol Head Neck Surg 2006;135:603-7.

VOICE HANDICAP INDEX MEASUREMENT OF PATIENTS WHO UNDERWENT REFLUX OPERATION

Year 2020, , 276 - 280, 01.07.2020
https://doi.org/10.18229/kocatepetip.735941

Abstract

OBJECTIVE: In this study; it was aimed to compare the voice handicap indices (VHI) of the patients who were operated for reflux to compare the preoperative and 3 months postoperative voice handicap.
MATERIAL AND METHODS: 30 patients operated by operated by Afyonkarahisar Health Sciences University General Surgery Clinic between 2014-2017 due to reflux were compared compared in terms of preoperative and postoperative 3rd month voice handicap indices (VHI) by Afyonkarahisar Health Sciences University Ear Nose Throat Clinic.
RESULTS: Sixteen (53%) of the patients included in the study were male and 14 (47%) were female. The average age is 32.45 ± 10.16. Compared with the preoperative period, there was a statistically significant improvement in VHI total score and functional, physical and emotional subgroup scores after the operation.
CONCLUSIONS: In conclusion, in this study, a significant relationship was found between reflux surgery and voice handicap index scores.

References

  • 1. Chen CL, Robert JJ, Orr WC. Sleep symptoms and gastroesophageal reflux. J Clin Gastroenterol 2008;42:13-7.
  • 2. Sveen S. Symptom check: is it GERD? J Contin Educ Nurs 2009;40:103-4.
  • 3. Levine JS. Management of Barret Esophagus. Primary Care Case Reviews 2002;5:68-76.
  • 4. Hogan WJ, Shaker R. Medical treatment of supraesophageal complications of gastroesophageal reflux disease. Am J Med 2001;111:197-201.
  • 5. Castell DO, Mainie I, Tutuian R. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc 2005;116:321-3.
  • 6. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;9:15-25.
  • 7. Yorulmaz İ. Larengofarengeal reflü, derleme. KBB-Forum 2002; 1(1):22-34.
  • 8. Field SK, Unxderwood M, Brant R, Cowie RL. Prevelance of gastroesophageal reflux symptoms in asthma. Chest 1996; 109: 316-22. 64
  • 9. Harding SM, Guzzo MR, Richter JE. 24-h eshophageal pH testing in asthmatics: Respiratory symptom correlation with esophageal acid events. Chest 1999; 115: 654-9.
  • 10. Irwin RS, Curley FJ, French CL. Difficult to control asthma contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-9.
  • 11. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24- hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(Suppl 53):1-78.
  • 12.Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000; 123:385-8.
  • 13.Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001; 111:1735-41.
  • 14.Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageallaryngeal reflux. J Gastrointest Surg 2002; 6: 189-94.
  • 15.Rouev P, Chakarski I, Doskov D, et al. Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 2005; 19: 476-80.
  • 16.Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985:94:516-9.
  • 17.Book DT, Rhee JS, Toohill RJ, Smith TL. Perspectives in laryngopharyngeal reflux: An international survey. Laryngoscope 2002; 112:1399-406.
  • 18.Goldberg M, Noyek AM, Pritzker KPH. Laryngeal granuloma secondary to gastroesophageal reflux. J Otolaryngol 1978; 7: 196-202. (PMID: 691085).
  • 19.Miko TL: Peptic (contact ulcer) granuloma of the larynx. J Clin Pathol 1989; 42: 800-4. (PMID: 2768520)
  • 20.Olson NR: Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991; 24:1201-1213. (PMID: 1754220).
  • 21. Kuhn I, Toohill RJ, Ulualp SO, Kulpa J, Hofmann C, Arndorfer R, Shaker R: Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 1998; 108:1146-1149. (PMID: 9707233).
  • 22. Jindal JR, Milbrath MM, Shaker R, Hogan WJ, Toohill RJ: Gastroesophageal reflux disease as a likely cause of idiopathic subglottic stenosis. Ann Otol Rhinol Laryngol 1994; 103:186-191. (PMID: 8122834). 70
  • 23. Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ: Carcinoma of the larynx in patients with gastroesophageal reflux, Am J Otolaryngol 1996; 17:386-90. (PMID: 8944297).
  • 24. Morrison MD: Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988; 99: 370-3. (PMID: 3148885).
  • 25. Ward PH, Hanson DG: Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988; 98: 1195-9. (PMID: 3185074).
  • 26. Öktem F, Toprak M, Ada M, Öztürk Ö: Larenks kanseri etyolojisinde laringofaringeal reflünün yeri. Türk ORL Arşivi 2000; 38: 28-32.
  • 27. Sataloff RT, Abaza MM. İmpairment, disability and other medical-legal aspects of dysphonia. Otolaryngol Clin North Am. 2000; 33 (5): 1143-1152.
  • 28. Speyer R, Bogaarrdt HCA, Passos VL, Roodenburg NP, Zumach A, Heinen MA et al.
  • 29. Gelfer MP, Pazera JF. Maximum duration of sustained /s/ and /z/ and s/z ratio with controlled intensity. J Voice. 2006; 20: 369-79.
  • 30. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. Voice. 1998; 12 (4): 540- 550.
  • 31. Jacobson BH, Johnson A, Grywasky C. The Voice Handikap Index (VHI): development and validation. J Voice. 1998; 12: 540-550.
  • 32. Mc Croy E. Voice therapy outcomes in vocal fold nodules: a retrospective audit. Int J Lang Commun Disord. 2001; 36: 19-24.
  • 33. Amir O, Tavor Y, Leibovitzh T, Ashkenazi O, Michael O, Primov-Fever A, et al. Evaluating the validity of the Voice Handicap Index-10 (VHI-10) among Hebrew speakers. Otolaryngol Head Neck Surg 2006;135:603-7.
There are 33 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Articles
Authors

Şahin Ulu 0000-0002-5462-9520

Murat Akıcı 0000-0001-6739-0670

Mümtaz Erakın 0000-0001-9558-6005

Selçuk Kuzu 0000-0002-0511-9874

Publication Date July 1, 2020
Acceptance Date June 5, 2020
Published in Issue Year 2020

Cite

APA Ulu, Ş., Akıcı, M., Erakın, M., Kuzu, S. (2020). REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. Kocatepe Tıp Dergisi, 21(3), 276-280. https://doi.org/10.18229/kocatepetip.735941
AMA Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. July 2020;21(3):276-280. doi:10.18229/kocatepetip.735941
Chicago Ulu, Şahin, Murat Akıcı, Mümtaz Erakın, and Selçuk Kuzu. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi 21, no. 3 (July 2020): 276-80. https://doi.org/10.18229/kocatepetip.735941.
EndNote Ulu Ş, Akıcı M, Erakın M, Kuzu S (July 1, 2020) REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. Kocatepe Tıp Dergisi 21 3 276–280.
IEEE Ş. Ulu, M. Akıcı, M. Erakın, and S. Kuzu, “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”, KTD, vol. 21, no. 3, pp. 276–280, 2020, doi: 10.18229/kocatepetip.735941.
ISNAD Ulu, Şahin et al. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi 21/3 (July 2020), 276-280. https://doi.org/10.18229/kocatepetip.735941.
JAMA Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. 2020;21:276–280.
MLA Ulu, Şahin et al. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi, vol. 21, no. 3, 2020, pp. 276-80, doi:10.18229/kocatepetip.735941.
Vancouver Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. 2020;21(3):276-80.

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.